Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 — PRINCIPLE Trial

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. — Read on http://www.principletrial.org/news/asthma-drug-budesonide-shortens-recovery-time-in-non-hospitalised-patients-with-covid-19/

The effect of respiratory activity, non‐invasive respiratory support and facemasks on aerosol generation and its relevance to COVID‐19 – Wilson – – Anaesthesia – Wiley Online Library

The effect of respiratory activity, non‐invasive respiratory support and facemasks on aerosol generation and its relevance to COVID‐19 – Wilson – – Anaesthesia – Wiley Online Library — Read on associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/full/10.1111/anae.15475

Early Release – Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa) – Volume 27, Number 5—May 2021 – Emerging Infectious Diseases journal – CDC

Early Release – Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa) – Volume 27, Number 5—May 2021 – Emerging Infectious Diseases journal – CDC — Read on wwwnc.cdc.gov/eid/article/27/5/21-0514_article